Pricing

Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney

CEO

Mark Timney

Collapse

Spencer Guthrie

Co-Founder & COO

Glen Firestone

Chief Business Officer

Gregory Bell

Chief Medical Officer

Jonathan Wall

Co-Founder & Interim Chief Scientific Officer

James Testa

VP, Finance

Michael L. Klein

Head, CMC

Christine Huh

Head, Human Resources

Andy Vick

Vice President, Head Of Toxicology, Drug Disposition, And Pk/pd

Daniel Kim

Associate Director, Translational Medicine Operations

Lesley Davis

Director Of Quality

Mike Klein

Senior Vice President, Head of CMC

Nicolas Angell

Executive Director, Analytical and Formulation Development

Dave Conroy

Head of Program Management

Matthew Meldorf

Senior Vice President Clinical Development

Teams

+10

Regulatory and Scientific Development

13 members

Clinical Operations and Development

7 members

Leadership Team

6 members

Similar companies

Werewolf Therapeutics

1 follower

Thermo Fisher Scientific

162 followers

Illumina

67 followers

Exact Sciences

15 followers

Natera

13 followers

Exelixis

11 followers

Cytokinetics

11 followers

Ultragenyx Pharmaceutical

10 followers

Immunovant

5 followers

Pendulum

4 followers

Merck

211 followers

Explore companies